Dr. Su Xiaodi has served as the company’s Non-Executive Director since May 2020 and is mainly responsible for supervising the management of the board of directors. Dr. Su Xiaodi received a bachelor’s degree in Biological Sciences from Shanghai Fudan University in 2008. She obtained a PhD in immunology and microbial pathogenesis from Weill Medical College of Cornell University. From 2014 to 2015, he engaged in postdoctoral research at the hospital for special surgery in New York, USA. She has approximately 6 years of experience in management consulting and investment in the biopharmaceutical industry.